8-K: Green Thumb Shifts to Fixed Annual Licensing Fees

Green Thumb Industries amended its brand licensing agreements with RYTHM subsidiaries, transitioning from revenue-based fees to fixed annual payments totaling $70 million to ensure Nasdaq compliance.

Summary

• Green Thumb Industries Inc. (GTI Core, LLC) amended its Trademark and Recipe License Agreements with VCP IP Holdings, LLC and MC Brands LLC, both wholly-owned subsidiaries of RYTHM, Inc.
• The amendments, effective April 1, 2026, change the consideration for license rights from monthly sales-based fees to fixed annual cash fees.
• The annual fee for the RYTHM, Beboe, Dogwalkers, Doctor Solomons, &Shine, and Good Green brands is $64.0 million, payable in monthly installments.
• The annual fee for the incredibles brand is $6.0 million, payable in monthly installments.
• The total fixed annual licensing fees amount to $70.0 million.
• These annual fees will be increased on January 1 of each year, subject to an annual increase based on published consumer price index changes, with a maximum year-over-year increase of 10%.
• The amendments were made to ensure RYTHM's compliance with Nasdaq Capital Market listing standards regarding revenue derived from the federally illegal cannabis industry.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a necessary and strategically sound move to address regulatory compliance, providing stability for RYTHM's Nasdaq listing and predictable costs for Green Thumb, despite the loss of direct sales-based alignment.

Positives

• The transition to fixed annual fees provides predictable costs for Green Thumb and predictable revenue for RYTHM, potentially simplifying financial forecasting.
• The amendments address Nasdaq compliance concerns for RYTHM, which could stabilize its listing status and reduce regulatory uncertainty.
• Green Thumb shareholders are positioned to benefit from RYTHM's long-term growth and value creation, as Green Thumb is a significant shareholder in RYTHM.

Negatives

• Green Thumb will now pay a fixed annual fee of $70 million regardless of the sales performance of the licensed brands, which could be a disadvantage if sales decline or grow slower than anticipated.
• The fixed fee structure removes the direct alignment between licensing costs and sales performance that existed with the previous revenue-based fees.
• The annual fee is subject to CPI-based increases (two times the Published CPI Rate, capped at 10%), meaning costs will rise over time.

Risks

• Regulatory Compliance: RYTHM's compliance with Nasdaq listing standards regarding revenue from the federally illegal cannabis industry remains a key factor, and this amendment is a direct response to that. Future regulatory changes or interpretations could still impact the business model.
• Related Party Transactions: The agreements are between Green Thumb and its indirect subsidiary, RYTHM, where Green Thumb's CEO also serves as RYTHM's Chairman and Interim CEO, raising potential conflicts of interest, though the filing notes compliance with MI 61-101.
• Market Performance: Green Thumb is now committed to a fixed annual payment regardless of the market performance of the licensed brands, which could become a burden if sales underperform.
• Inflationary Pressure: The annual fee is subject to CPI-based increases, which could lead to higher costs for Green Thumb in an inflationary environment.

Future Outlook

The company expects to continue growing and scaling the licensed brands, with management expressing commitment to expanding their reach. The new fixed fee structure aims to provide stability and ensure compliance with Nasdaq listing standards for RYTHM, which Green Thumb expects to benefit from as a significant shareholder.

Management Comments

• "As a significant shareholder in RYTHM, Green Thumb shareholders are positioned to benefit from RYTHM’s long-term growth and value creation."
• "Green Thumb has grown and scaled these brands for more than a decade, and we remain as committed as ever to expanding their reach."

Industry Context

StockSavvy.ai notes that this amendment highlights the ongoing challenges and complexities faced by cannabis companies operating in the U.S. due to federal illegality. The need for RYTHM to adjust its revenue recognition model to comply with Nasdaq listing standards underscores the regulatory hurdles that can impact business structures and financial reporting for multi-state operators (MSOs) and their affiliates. This move towards fixed fees could be a trend for other cannabis companies seeking to maintain or achieve mainstream exchange listings, potentially shifting risk profiles from variable sales-based costs to fixed operational expenses.

Comparison to Industry Standards

• StockSavvy.ai observes that the shift from revenue-based to fixed licensing fees is a direct response to unique regulatory pressures within the U.S. cannabis industry, particularly concerning Nasdaq listing standards for companies with federally illegal revenue streams. This is not a standard practice in mature, federally legal consumer packaged goods (CPG) licensing, where royalty rates are typically percentage-based (e.g., 3-10% of net sales) to align licensor and licensee incentives.
• Comparable situations are rare outside the cannabis sector, as most industries do not face such federal-state legal discrepancies impacting exchange listings. However, in other highly regulated sectors, companies often restructure agreements to meet specific compliance requirements, sometimes at the expense of optimal commercial terms.
• The fixed fee of $70 million annually for a portfolio of established cannabis brands represents a significant fixed cost for Green Thumb, which would need to be benchmarked against the historical revenue generated by these brands to assess the financial impact. Without historical revenue figures for these specific licensed brands, a direct comparison to industry-standard royalty rates (e.g., for food, beverage, or health & beauty CPG brands) is difficult, but the fixed nature itself is a deviation driven by regulatory necessity rather than pure commercial optimization.

Related Party Transactions

• The amendments to the Trademark and Recipe License Agreements are between GTI Core, LLC (a wholly-owned subsidiary of Green Thumb Industries Inc.) and VCP IP Holdings, LLC and MC Brands LLC (wholly-owned subsidiaries of RYTHM, Inc.).
• Green Thumb Industries Inc. is an indirect owner of approximately 33% of the outstanding shares of common stock of RYTHM, Inc.
• Benjamin Kovler, Green Thumb's Chairman and Chief Executive Officer, also serves as the Chairman and Interim Chief Executive Officer of RYTHM, Inc.
• The transaction is considered a related party transaction under Canadian Multilateral Instrument 61-101 but is exempt from certain requirements as its aggregate value does not exceed 25% of Green Thumb's market capitalization.

Stakeholder Impact

• Shareholders (Green Thumb): Gain clarity on licensing costs and potential stability for RYTHM's Nasdaq listing, which could benefit Green Thumb as a significant shareholder. However, they bear the risk of fixed costs regardless of sales performance.
• Shareholders (RYTHM): Benefit from a stable, predictable revenue stream from licensing fees and improved compliance with Nasdaq listing standards, potentially enhancing investor confidence.
• Customers: No direct immediate impact on product availability or pricing is indicated.
• Employees: No direct impact on employment is indicated.

Next Steps

• RYTHM and Nasdaq staff will continue discussions to ensure compliance with listing standards.
• Green Thumb will file a material change report with applicable Canadian securities regulatory authorities.
• Annual adjustment of license fees on January 1 of each year based on CPI changes.

Key Dates

Recommendation

The shift to fixed licensing fees addresses a critical regulatory compliance issue for RYTHM, a significant affiliate of Green Thumb, which is a positive for long-term stability and market access. However, it also introduces a substantial fixed cost for Green Thumb, removing the direct alignment with sales performance. While the move is strategically sound for navigating the complex cannabis regulatory landscape, the financial impact requires further analysis against historical sales data of the licensed brands to fully assess its net effect on Green Thumb's profitability. The predictable cost structure is a double-edged sword, offering stability but also potential downside if brand sales underperform. Therefore, a "hold" recommendation is appropriate until the financial implications of this fixed cost structure can be more thoroughly evaluated against Green Thumb's overall performance and market conditions.

Keywords

Green Thumb Industries, RYTHM Inc., Cannabis, Licensing Agreement, SEC Filing, 8-K, Nasdaq Compliance, Fixed Fees, Intellectual Property, Marijuana, Consumer Packaged Goods, Related Party Transaction